Match Document Document Title
US20100183654 IMMUNOREACTIVE PROTEIN ORTHOLOGS OF EHRLICHIA CANIS AND E. CHAFFEENSIS  
The present invention concerns gp36 immunoreactive compositions for E. canis and gp 47 immunoreactive compositions for E. chaffeensis. In particular, epitopes for E. canis gp36 and E. chaffeensis...
US20100298207 PESTICIDAL PROTEINS AND METHODS FOR THEIR USE  
Compositions and methods for conferring pesticidal activity to bacteria, plants, plant cells, tissues and seeds are provided. Compositions comprising a coding sequence for a toxin polypeptide are...
US20050266050 Antimicrobial composition and method for use  
An antimicrobial composition and a method for administering the antimicrobial composition through the water or feed of livestock, wherein the antimicrobial composition is made up of lysozyme and...
US20150203503 1,6- DIAZABICYCLO [3,2,1] OCTAN-7-ONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS  
Compounds of Formula (I), their preparation and use in preventing or treating bacterial infections are disclosed.
US20070048752 Mass tags for quantitative analyses  
This invention pertains to methods, mixtures, kits and/or compositions for the determination of analytes by mass analysis using unique labeling reagents or sets of unique labeling reagents. The...
US20070009503 Antibiotic, Compositions Containing the Antibiotic, and Methods for Administering the Antibiotic and/or Said Compositions to Livestock  
An antibiotic comprising a protease-resistant bacteriocin derived from a lactic acid bacterium, and compositions thereof, are disclosed. A feed composition for livestock comprising the antibiotic...
US20090118179 Therapeutic Agent for Dentin-Pulp Complex Regeneration  
The present invention provides a therapeutic agent for regenerating a dentin-pulp complex, containing a basic fibroblast growth factor and/or a homolog thereof as an active ingredient. The present...
US20060105941 Mixed antibiotic codrugs  
Novel compounds which degrade in vivo into two or more different active antibiotics are disclosed herein. Methods, compositions, and medicaments related thereto are also disclosed.
US20100144603 METHODS AND USES THEREOF OF PROSAPOSIN  
The invention relates to methods for treating of tumor metastasis, methods for preventing, inhibiting, and predicting tumor recurrence and tumor metastasis, and methods of preventing cancer...
US20090291073 Compositions Comprising PKC-theta and Methods for Treating or Controlling Ophthalmic Disorders Using Same  
Compositions for treating or controlling: (i) an eye condition, disorder, or disease, or (ii) a degeneration of a component of an optic nerve system in a subject, comprise a PKC-θ inhibitor. The...
US20060217306 Systemic treatment of infections with defensins  
The present invention relates to methods for treating systemic microbial infections with defensin antimicrobial peptides. The invention also relates to a medicament and a method for preparing a...
US20110028387 METHODS OF SCREENING OF PP1-INTERACTING POLYPEPTIDES OR PROTEINS, PEPTIDES INHIBITING PP1c BINDING TO Bcl-2 PROTEINS, BCL-XL AND BCL-W, AND USES THEREOF  
The invention relates to methods for identifying novel PP1-interacting polypeptides and proteins, compounds which are able to inhibit the binding of PP1c to certain factors naturally interacting...
US20060024374 Pharmaceutical compositions suitable for the treatment of ophthalmic diseases  
Pharmaceutical compositions for the treatment of ophthalmic diseases, suitable for topical ocular administration and for systemic administration, comprising solid lipid nanoparticles (SLNs) with a...
US20090317381 CLEARANCE OF ABNORMAL IGA1 IN IGA1 DEPOSITION DISEASES  
The present invention relates to proteins which specifically bind to IgA1 and which have been modified to comprise either O- or N-linked glycans. The invention encompasses methods for decreasing...
US20110245153 Neutralizing Agents for Bacterial Toxins  
Stabilized variable regions of the T cell receptor and methods of making the same using directed evolution through yeast display are provided. In one embodiment, the variable region is variable...
US20090104257 Liposomal Vancomycin Formulations  
The present disclosure relates in part to liposomal vancomycin compositions having low lipid to drug ratios and high concentration of vancomycin. The present disclosure also relates in part to...
US20050089509 Treatment of Francisella infection with an IFN-gamma inducer and a chemotherapeutic agent  
The present invention concerns methods and compositions for treating or preventing Francisella infection in a subject comprising obtaining an inducer of IFN-γ, obtaining a chemotherapeutic agent,...
US20110243958 ANTIMICROBIAL AGENTS THAT TARGET BACTERIAL VKOR  
Aspects of the invention relate to a method for inhibiting the growth of a microbe that expresses bacterial vitamin K epoxide reductase (bVKOR). The method involves contacting the bacterial cell...
US20140287989 Compounds Binding to the Bacterial Beta Ring  
The present invention relates to compounds which bind to the hydrophobic pocket of the β clamp, i.e., to the surface of the β ring with which said protein interacts with other proteins of the...
US20050070463 Use of gram-negative bacterial membrane fraction for inducing the maturation of dendritic cells  
The invention relates to the use of a gram-negative bacterial membrane fraction, especially Klebsiella pneumoniae, for inducing the maturation of dendritic cells.
US20140287990 COMPOSITIONS AND METHODS TO CONCURRENTLY TREAT AND/OR PREVENT MULTIPLE DISEASES WITH CUPREDOXINS  
The present invention relates to compositions and methods to administer compositions comprising cupredoxin and/or cytochrome and/or variants, derivatives, truncations and structural equivalents of...
US20100099600 CANDIDATES AGAINST INFECTION  
The present invention relates to the use of plasminogen/plasmin and its derivatives as agents for enhancing host defense against infection or other infectious diseases. The invention also relates...
US20080026072 Antimicrobial Carbohydrates and Methods of Using Same  
Compositions useful for inhibiting the growth of bacteria, including bacteria that can cause gastric ulcers, are provided. In addition, transgenic organism that can produce such compositions are...
US20100009911 Osteogenic synergic composition  
The invention relates to an osteogenic synergic composition comprising at least one osteogenic growth factor, and at least one growth factor having a chemoattractant and angiogenic capacity. It...
US20090123551 GASTROINTESTINAL DELIVERY SYSTEMS  
Provided herein are compositions suitable for the delivery of therapeutic agents to the gastrointestinal tract. Also provided herein are methods for treating, preventing or alleviating disorders...
US20060258571 Antibacterial ester macrocycles  
The invention relates to antibacterial ester macrocycles of formula (I), methods for the production thereof, and the use thereof for producing medicaments used for the treatment and/or prophylaxis...
US20090214424 Human glycoprotein hormone superagonists and uses thereof  
The present invention provides improved methods of imaging, targeted therapy and detection and diagnostics using modified glycoprotein hormones having increased activity over wild-type hormones.
US20140255476 COMPOSITIONS, DEVICES, AND METHODS FOR TREATING INFECTIONS  
Compositions, devices, and methods for treating infections.
US20130012428 LIQUID ANTIMICROBIAL COMPOSITIONS  
The present invention relates to liquid antimicrobial compositions having a high anti-microbial activity. The invention further relates to a method for preparing the liquid antimicrobial...
US20120108499 PEPTOID COMPOUNDS  
The invention relates to new peptoid compounds of formula (I), as well as their use in the treatment of bacterial infections, such as those caused by vancomycin resistant microorganisms, and to...
US20100055138 METHODS AND TOPICAL FORMULATIONS COMPRISING COLLOIDAL METAL FOR TREATING OR PREVENTING SKIN CONDITIONS  
In preferred embodiments, the present invention relates to compositions comprising colloidal metals and/or metals for the treatment and prevention of skin conditions and/or diseases. More...
US20080233149 Use of Erythropoietin for Enhancing Immune Responses and for Treatment of Lymphoproliferative Disorders  
The present invention relates to the use of erythropoietin (EPO) for enhancing immune responses and for the treatment of lymphoproliferative disorders, excluding multiple myeloma. Accordingly to...
US20120142584 NOVEL TRANSPORTER CONSTRUCTS AND TRANSPORTER CARGO CONJUGATE MOLECULES  
The present invention relates to novel transporter constructs of the generic formula (I) DlLLLxDm(LLLyDn)a and variants thereof. The present invention also refers to transporter cargo conjugate...
US20070235035 Method Of Producing Auto Induced Physiological Processes In A Body Cavity And A Device For Using It  
This invention relates to a method of producing an auto induced biological barrier against spermatozoids and/or other microorganisms including viruses and/or pre cancers or non invasive cancers...
US20080306001 TRANSCRIPTIONAL MODULATION OF EXTRACELLULAR MATRIX (ECM) OF DERMAL FIBROBLASTS  
The present invention includes peptides, compositions as well as their use for the prevention or treatment of various age related or pathological conditions of skin or other tissues including skin...
US20070027088 Peptides and mimetics for reducing symptoms of toxic shock syndrome and septic shock  
This invention relates to compositions and methods for providing protection against, or reducing the severity of, toxic shock syndrome, septic shock, food poisoning, and autoimmune diseases which...
US20150209405 ANTIBACTERIAL COMPOSITION FOR TOPICAL USE  
The present invention relates to an antibacterial composition, preferably for topical use, comprising triethyl citrate and a peptide consisting of 15 amino acids of sequence FAKALKALLKALKAL-NH2,...
US20090053816 HEMOGLOBIN-BASED METHODS FOR PROPHYLAXIS, DIAGNOSIS AND/OR TREATMENT OF RETINAL DISORDERS  
The presently disclosed subject matter provides methods of diagnosing retinal disorders in subjects by measuring hemoglobin and modified hemoglobin in the subjects. The presently disclosed subject...
US20060025368 Growth hormone releasing hormone enhances vaccination response  
This invention discloses compositions and methods of: vaccinating a subject; enhancing the vaccination efficiency; preparing a subject prior to vaccination response; and improving the clinical...
US20130011366 Therapeutic Agent for infections, and treatment method using the same  
(Problems) To provide a therapeutic agent for infections comprising granulysin as an active ingredient which has little side effect and no cytotoxicity and to which bacteria can hardly acquire...
US20100184682 Composition and Methods for the Inhibition of Membrane Fusion by Paramyxoviruses  
Fusion of the membrane of enveloped viruses with the plasma membrane of a receptive host cell is a prerequisite for viral entry and infection and an essential step in the life cycle of all...
US20070166348 KERATIN BIOCERAMIC COMPOSITIONS  
A malleable bone graft composition is described. The composition comprises: (a) keratose; (b) particulate filler; (c) antibiotic; and (f) water. The invention may be provided in sterile form in an...
US20120020950 ANTIBACTERIAL COMPOUNDS  
Disclosed are compounds of formula (I), which are of use in the treatment of bacterial diseases and infections, to compositions containing those compounds and to methods of treating bacterial...
US20150230466 ANTIMICROBIAL COMPOSITION FOR INHIBITING MICROBIAL ORGANISMS AND THE METHOD THEREOF  
The invention relates to a method of controlling or combating microbial organism by applying an antimicrobial peptide to the microbial organisms, wherein said antimicrobial peptide derived from...
US20150045287 ANTIMICROBIAL COMPOSITION FOR INHIBITING MICROBIAL ORGANISMS AND THE METHOD THEREOF  
The invention relates to a method of controlling or combating microbial organism by applying an antimicrobial peptide to the microbial organisms, wherein said antimicrobial peptide derived from...
US20100183501 Medical Devices With Nanotextured Titanium Coating  
A system for treating a vascular condition includes a catheter, a stent disposed on the catheter, the stent having a stent framework including a core, the core having an outer surface and a pure...
US20050124533 Glucocorticoid blocking agents for increasing blood-brain barrier permeability stan-261con  
Glucocorticoid blockers, including glucocorticoid receptor antagonists, are effective to prevent glucocorticoid-induced decrease in permeability of the blood-brain barrier and to increase the...
US20050096262 Helicobacter pylori adhesion inhibitor  
This invention relates to a Helicobacter pylori adhesion inhibitor that is capable of eliminating Helicobacter pylori associated with the development of peptic ulcer from the stomach, a method for...
US20080220097 FORMULATIONS CONTAINING CYNARA SCOLYMUS AND PHASEOLUS VULGARIS EXTRACTS WHICH ARE USEFUL IN THE TREATMENT OF OBESITY  
The present invention relates to a Cynara scolymus extract with a high content of caffeoylquinic acids, and a composition containing said Cynara scolymus extract with a Phaseolus vulgaris extract....
US20080038299 Skincare Compositions Comprising Salicylic Acid  
There is disclosed a skincare composition suitable for topical application to the skin. The composition comprises alicylic acid or a salt thereof and hydrolysed milk protein. The composition is...